Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONET BRIDGE: Cangrelor Bridge for Coronary Stent Patients Undergoing Surgery
NCT03862651Phase 2Unknown
- Sponsor
- Ospedale Santa Croce e Carle
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
01
Overview
Phase 2, randomised, double-blind trial in coronary artery disease (CAD) comparing Cangrelor Arm with Placebo Arm (2 arms). Primary endpoint: Residual Platelet Reactivity. Status: unknown.
02
Drugs
cangrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03862651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03862651.